TOP TIERMARKET NEWSWIRE
News & sentiment

INOVIO PHARMACEUTICA (INO) — News & AI sentiment

INOVIO PHARMACEUTICA (INO) news roundup. 5 stories in the past week, 13 over 30 days. Average 30-day sentiment is 51.9/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
5
avg sentiment 44/100
30d stories
13
avg sentiment 51.9/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

INO news in the last 24 hours, 7 days, 30 days and 90 days

How much INO coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowINO storiesAvg AI sentimentRead
Last 24 hours0no coverage
Last 7 days544/100INO headlines →
Last 30 days1351.9/100INO headlines →
Last 90 days4149.4/100INO headlines →

Latest stories on INO

2d ago
2d ago
3d ago
4d ago
4d ago
Sep 1
Sep 1
Aug 25
Aug 20
Aug 19
Aug 18
Aug 17
Aug 14
Aug 13
INOVIO shares jump 18% after Q2 beat
Seeking Alpha68 · bullishearnings
Aug 13
Aug 13
H.C. Wainwright reiterates Neutral on Inovio stock, $2.50 target
Investing.com Analyst Ratings50 · neutralanalyst
Aug 13
Jefferies upgrades Inovio stock rating on FDA review progress
Investing.com Analyst Ratings63 · neutralanalyst
Aug 13
Aug 13
Aug 13
Inovio (INO) Q2 2026 Earnings Call Transcript
Yahoo Finance63 · neutralearnings
Aug 13
Inovio (INO) Q2 2026 Earnings Call Transcript
The Motley Fool59 · neutralearnings
Aug 13
Aug 13
Aug 12
Aug 12
Open INO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →